Public-private collaboration, including 14 global (re)insurers, addresses critical risks faced by COVID19 vaccines and other health commodities during distribution.
Lloyd’s and Parsyl, Inc. today announced the launch of the Global Health Risk Facility (GHRF) which will make available billions of dollars of insurance coverage, together with risk mitigation services to help protect and support the global distribution of COVID-19 vaccines as well as critical health commodities.
The launch of the GHRF includes support from the U.S International Development Finance Corporation (DFC) which has approved up to $26.7M for the Facility. The DFC loan will be used to capitalize the new public-private Syndicate 1796, and allow the GHRF to offer cost-effective insurance policies for shipments of vaccines and medical products to developing countries.
The GHRF is an alliance of insurance and technology partners* that together will provide comprehensive insurance and risk mitigation services for the storage and transit of life-saving medical supplies such as temperature sensitive vaccines and medicines, diagnostics, PPE and ancillary cold chain equipment. The facility is anchored by Syndicate 1796, which operates at Lloyd’s and will begin underwriting in January 2021. Syndicate 1796 is the first public-private partnership to address a global health emergency in Lloyd’s 330-year history.
Distributing cold chain vaccines and pharmaceuticals safely around the world is extraordinarily complex and they can easily spoil if not properly maintained, especially at the last mile of transit where infrastructure is weak. The GHRF will protect the quality of the goods and the financial investments made to supply and distribute them at a global level.
The proposed loan from DFC, America’s development bank, will enable Syndicate 1796 to write insurance policies for the distribution of health commodities to eligible low, lower-middle, and upper-middle income countries. The funds will go towards Funds at Lloyd’s (FAL) to support underwriting and provide customers with the security of Lloyd’s A+ rating from Standard & Poor’s, AA- from Fitch and A from A.M. Best. Parsyl and DFC are on track to finalize loan terms and documentation in the coming weeks.
A critical feature of the insurance platform will be the Risk Management Accelerator (RMA), which is separately funded by participating syndicates and donors and supported by the risk consulting services of AXA XL. The RMA will provide funding and services to enable eligible GHRF clients to access better data and risk mitigation solutions which will strengthen the vaccine supply chain. The RMA will fund a range of services, including conducting surveys of storage locations, supply chain risk evaluations and technology enabled data collection.